Wednesday, 16 August 2017

Japan News

  • India urges Japan to provide wider pharma market access

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 14 Oct, 2016

    Singapore: The Indian commerce Minister, Ms Nirmala Sitharaman has urged Japan to provide Indian pharmaceutical sector with a wider share and greater market access in Japan. Ms Sitharaman f...Read more

  • Zydus Cadila, Takeda to co-develop vaccine for chikungunya

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 23 Sep, 2016

    Singapore: Japan's Takeda pharmaceuticals has joined hands with India-based Zydus Cadila in an aim to co-develop a vaccine for chikungunya. As per the terms the companies will jointly devel...Read more

  • Japan market forecast

    Japan |  Opinion | By BioSpectrum Bureau | 0 Comment | 20 Jan, 2016

    Singapore: Japan's demographic profile will continue to create revenue earning opportunities for the pharmaceuticals and healthcare industry. Supported by an expansive universal healthcare ...Read more

  • Stem cell scientist sues Nobel laureate for deception

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 17 May, 2013

    Singapore: Dr Rongxiang Xu, a scientist who claims to be the founder of human body regenerative restoration science, has filed a lawsuit against Dr Shinya Yamanaka, one of the winners of th...Read more

  • Niigata Univ stroke therapy license for Shimojani

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 25 Feb, 2013

    Singapore: Shimojani obtained exclusive license from Japan's Niigata University for worldwide development and commercialization of an invention that reduces the risk of hemorrhage in acute...Read more

  • Astellas prostrate cancer drug gets EU nod

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 25 Jun, 2013

    Singapore: The European Commission has approved Xtandi (enzalutamide) capsules for the treatment of men with metastatic castration-resistant prostate cancer, whose disease has progressed on...Read more

  • Columbia Asia receives $101mn investment from Mitsui & Co.

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2016

    Singapore: Columbia Asia has announced it is receiving $101 million in investment from Mitsui & Co., Ltd. Columbia Asia, part of Seattle-based Columbia Pacific Management, has 27 hospi...Read more

  • Teijin, Versartis partner for commercialization of Somavaratan in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 11 Aug, 2016

    Singapore: Teijin Limited and Versartis, Inc. has announced that the companies and their wholly owned subsidiaries have entered into an exclusive license and supply agreement for the develo...Read more

  • Tivozanib shows superiority over sorafenib in trial

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 May, 2012

    Singapore: Investigational agent, tivozanib, has demonstrated statistically significant and clinically meaningful PFS superiority versus approved targeted agent sorafenib in advanced Renal ...Read more

  • Chugai gets positive outcome from Actemra Subcutaneous Injection trials

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 17 May, 2016

    Japanese pharmaceutical giant Chugai Pharmaceutical Co Ltd has announced that its Actemra Subcutaneous Injection (Actemra), the humanized antihuman IL-6 receptor monoclonal antibody, succes...Read more

  • Prosetta Biosciences, Takeda to co-discover drugs for neurodegenerative diseases

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 03 May, 2016

    Prosetta Biosciences Inc. has entered into a Feasibility and First Right of Negotiation Agreement with Japan's Takeda Pharmaceutical Company Limited, to conduct a feasibility study for the ...Read more

  • Histogenics to develop Purpose's NeoCart for Japanese Market

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 11 May, 2016

    Histogenics Corporation, a NASDAQ-listed regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, announced that it has acquired the de...Read more

  • NCRM gets Japanese patent for nanotechnology-based corneal stem cell transplant

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2016

    Tokyo: Corneal endothelial precursor cell transplantation methodology, employing a Nanocomposite gel sheet has been awarded a Japanese patent to Chennai-based Nichi-in Centre for Regenerati...Read more

  • Allergan's Botox Vista receives marketing authorization in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 25 May, 2016

    Dublin-headquartered Allergan plc has announced that the Japanese Ministry of Health, Labour and Welfare has approved an additional use for Botox Vista (Allergan's botulinum toxin type A pr...Read more

  • Microfluidics expert becomes Japan S&T agency licensee

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2012

    Singapore: Microfluidics expert Dolomite is now a licensee of Japan Science and Technology Agency (JST) under JST's microdroplet generation technology. Dolomite is authorized to grant sub-...Read more

  • Daiichi Sankyo to reorganize supply chain business

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2012

    Singapore: Japan's Daiichi Sankyo has decided to reorganize three of its Japanese supply chain subsidiaries, Daiichi Sankyo Propharma (DSPP), Daiichi Sankyo Chemical Pharma (DSCP) and Daiic...Read more

  • Daiichi Sankyo announces closure of its Hiratsuka Plant

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 04 Apr, 2016

    Singapore: Daiichi Sankyo Company, Limited (hereafter Daiichi Sankyo) has announced its decision to close the Hiratsuka plant owned by its subsidiary, Daiichi Sankyo Chemical Pharma Co., Lt...Read more

  • BIOTEC launches microbe management course

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 22 Jan, 2013

    Singapore: Thailand's flagship biotechnology organization, BIOTEC, NITE Biological Resource Center (NBRC) of Japan and World Data Center for Microorganisms (WDCM), have launched a training...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls